Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade at the End of Kidney Transplantation Surgery
Conditions: Kidney Transplant; Complications; Postoperative Residual Curarization; Postoperative Residual Weakness Interventions: Drug: Sugammadex; Drug: Neostigmine Sponsor: University of Colorado, Denver Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brain | Kidney Transplant | Kidney Transplantation | Neurology | Neurosurgery | Research | Transplant Surgery | Transplants | Urology & Nephrology